The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma Via a SNAI1-dependent Mechanism.
Xin Zheng,Natalia B. Rumie Vittar,Xiaohong Gai,Maite G. Fernandez-Barrena,Catherine D. Moser,Chunling Hu,Luciana L. Almada,Angela L. McCleary-Wheeler,Sherine F. Elsawa,Anne M. Vrabel,Abdirashid M. Shire,Andrea Comba,Snorri S. Thorgeirsson,Youngsoo Kim,Qingguang Liu,Martin E. Fernandez-Zapico,Lewis R. Roberts
DOI: https://doi.org/10.1371/journal.pone.0049581
IF: 3.7
2012-01-01
PLoS ONE
Abstract:The role of the epithelial-to-mesenchymal transition (EMT) during hepatocellular carcinoma (HCC) progression is well established, however the regulatory mechanisms modulating this phenomenon remain unclear. Here, we demonstrate that transcription factor glioma-associated oncogene 1 (GLI1) modulates EMT through direct up-regulation of SNAI1 and serves as a downstream effector of the transforming growth factor-β1 (TGFβ1) pathway, a well-known regulator of EMT in cancer cells. Overexpression of GLI1 increased proliferation, viability, migration, invasion, and colony formation by HCC cells. Conversely, GLI1 knockdown led to a decrease in all the above-mentioned cancer-associated phenotypes in HCC cells. Further analysis of GLI1 regulated cellular functions showed that this transcription factor is able to induce EMT and identified SNAI1 as a transcriptional target of GLI1 mediating this cellular effect in HCC cells. Moreover, we demonstrated that an intact GLI1-SNAI1 axis is required by TGFβ1 to induce EMT in these cells. Together, these findings define a novel cellular mechanism regulated by GLI1, which controls the growth and EMT phenotype in HCC.